Edesa Biotech, Inc.
EDSA
$4.94
-$0.43-8.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 25.74% | -2.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 83.52% | -5.21% | |||
| Operating Income | -83.52% | 5.21% | |||
| Income Before Tax | -87.64% | -0.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -87.67% | -0.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -87.67% | -0.87% | |||
| EBIT | -83.52% | 5.21% | |||
| EBITDA | -84.43% | 5.26% | |||
| EPS Basic | -75.20% | 10.76% | |||
| Normalized Basic EPS | -67.54% | 16.01% | |||
| EPS Diluted | -75.20% | 10.76% | |||
| Normalized Diluted EPS | -66.23% | 16.01% | |||
| Average Basic Shares Outstanding | 7.13% | 13.01% | |||
| Average Diluted Shares Outstanding | 7.98% | 13.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||